BrachyDOSE is a medtech startup that offers a game-changing cancer treatment quality control tool designed to empower oncology doctors to provide 100% accurate and error-free radiotherapy treatment. The company provides a patient-centric, data-driven measurement system that combines hardware and software to prevent up to 100% of treatment-caused injuries in radiotherapy procedures.

The solution includes a disposable sensor in the shape of a flexible tube, a scanner to retrieve data, and an injury prediction algorithm driven by machine learning. This system helps doctors by displaying warning announcements about dose mismatches, injury risks, and treatment outcomes, reducing mistakes, saving medical personnel time, lowering hospital costs, and improving patient safety.

Our mission is to provide medical professionals with empowering innovative solutions for safe and highly effective treatment.

Our vision is to help medical professionals win the battle against cancer treatment-caused side effects in every hospital worldwide.

Our core values include quality, innovation, and partnership.

Founded originally in 2014 as MB Šeši Partneriai, the company started with scientific research services in physical sciences. It pivoted to focus on brachytherapy treatment improvements after identifying critical problems in patient data accuracy during oncology hospital projects.

It successfully participated in the Kaunas Start-ups Acceleration program in 2018 and was renamed UAB Albametrics in 2021. In January 2024, the company was established as an independent startup named UAB BrachyDOSE.

BrachyDOSE is a Horizon 2020 Seal of Excellence holder, the winner of Kaunas Startup Accelerator, and a beneficiary of the EIT Health InnoStars Award.

Office Location: K. Baršausko g. 59-B507, Kaunas, Lithuania

Contact Email: [email protected]

LinkedIn: https://www.linkedin.com/company/brachydose/

Website: https://www.brachydose.net